BrainStorm Cell Therapeutics
BCLI
#10103
Rank
C$10.1 M
Marketcap
$1.55
Share price
14.87%
Change (1 day)
-86.00%
Change (1 year)

BrainStorm Cell Therapeutics (BCLI) - Total debt

Total debt on the balance sheet as of December 2024 : C$0.99 Million

According to BrainStorm Cell Therapeutics's latest financial reports the company's total debt is C$0.99 Million. A companyโ€™s total debt is the sum of all current and non-current debts.

BrainStorm Cell Therapeutics - Total debt on balance sheet (from 2002 to 2024)

Total debt by year

Year Total debt Change
2022-12-31C$5.55 M-14.2%
2021-12-31C$6.47 M-29.66%
2020-12-31C$9.2 M197.79%
2019-12-31C$3.09 M
2018-12-31N/A
2010-12-31C$0.13 M-64.82%
2009-12-31C$0.38 M-27.72%
2008-12-31C$0.53 M-64.96%
2007-12-31C$1.53 M17.26%
2006-12-31C$1.31 M
2006-03-31C$0.57 M
2004-03-31C$0.04 M31.67%
2003-03-31C$0.03 M90.93%
2002-03-31C$0.01 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
C$36.94 B 3,709,761.11%๐Ÿ‡บ๐Ÿ‡ธ USA
C$1.09 B 109,438.47%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.15 B 15,662.08%๐Ÿ‡บ๐Ÿ‡ธ USA
C$9.17 B 920,775.00%๐Ÿ‡บ๐Ÿ‡ธ USA
C$0.13 B 13,076.39%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA